Skip to main content
BROOKS · Health Care · 2026-08-07

Brooks Laboratories Ltd

Stage 1 · wk 9In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹60
-0.07% today
₹177 Cr · Micro cap
About this companyHealth Care· Labs & Life Sciences Services
Expand ▾

Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company's product portfolio includes liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and dry powder injections; formulations for antibiotics, pain management, and controlled drugs; and oncology products and hormonal injections, etc. It also provides regulatory compliance, custom branding and packaging, scalable production, and end-to-end support services. The company serves government health programs and public sector institutions, hospitals and medical colleges, defense and railways, corporate healthcare, and NGOs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan Nigeria, Lebanon, Mauritius, Sudan, Madagascar, DR Congo, Mozambique, LATAM, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

Visit company website →
P/E (TTM)
8.5
Forward 10.7
vs 52W High
-62.3%
₹37.1 lo₹159 hi
62.3% below 52W high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 9
1w13w26w
Week 9 — base building
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
-19.3%
200 DMA: ₹74.4 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.40x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
MA20 rolling over · -8.2% vs MA50 +7.7%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Labs & Life Sciences Services
↑ Building
Stage 2%
33.3%
20d Δ
+16.7pp
1M return
+18.9%
3M return
+20.0%
Industry Stage-2 % · last 20 days
Industry has 2 Stage 2 leaders. See Labs & Life Sciences Services Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-12 → 2026-08-07
S2 27w
S4 16w
S4 32w
2023-05-122026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 6w → S1 9w → S2 27w → S3 6w → S4 16w → S1 5w → S2 11w → S3 3w → S2 9w → S3 4w → S4 7w → S1 9w → S2 10w → S3 3w → S4 32w → S1 8w current
Total tracked: 167 weeks across 16 stage runs.
1M
-14.9%
3M
+20.2%
6M
-0.3%
YTD
-30.5%
1Y
-59.5%
Scan Membership
Breakout Watch
Latest: 2025-07-23
3 appearances in last 60 days. First seen: 2024-09-20.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S1
Wk 9 · Vol x
2026-08-06S1
Wk 8 · Vol x
2026-08-05S1
Wk 8 · Vol x
2026-08-04S1
Wk 8 · Vol x
2026-08-03S1
Wk 8 · Vol x
2026-07-31S1
Wk 8 · Vol x
2026-07-30S1
Wk 7 · Vol x
2026-07-29S1
Wk 7 · Vol x
2026-07-28S1
Wk 7 · Vol x
2026-07-27S1
Wk 7 · Vol x
2026-07-24S1
Wk 7 · Vol x
2026-07-23S1
Wk 6 · Vol x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹67.5
200 DMA
₹74.4
52W High
₹159
52W Low
₹37.1
5D Low
₹60
Resistance levels (recent highs)
20d High
₹69.9
60d High
₹77.2
120d High
₹78.1
250d High
₹159
Next resistance
+16.4%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.